Teva Pharmaceutical Industries Ltd (TEVA) insider trading

Every open-market stock purchase and sale by Teva Pharmaceutical Industries Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Roberto Mignone (Insider) and 7 others sold $17M in the last 90 days.
  • Last insider buy: David R. McAvoy (C-suite exec), $21K, 14 months ago.
  • Congress: Alan Armstrong bought $1K to $15K, 7 months ago.

Last 12 months: insiders bought $0 (0 buys) and sold $113M (46 sales). Last close $40.62 on Oct 21, 2026.

Recent TEVA insider trades

DateInsiderTradeValue
Sep 18, 2026Roberto Mignone (Insider)Sold$14.4M
Sep 18, 2026Brian Savage (C-suite exec)Sold$174K
Sep 18, 2026Brian Savage (C-suite exec)Bought (not open market)$156K
Sep 18, 2026Brian Savage (C-suite exec)Bought (not open market)$156K
Sep 18, 2026Brian Savage (C-suite exec)Sold$98.8K
Sep 18, 2026Brian Savage (C-suite exec)Sold$12.2K
Aug 21, 2026Amir Weiss (C-suite exec)Sold$261K
Aug 21, 2026Amir Weiss (C-suite exec)Sold$94.1K
Aug 21, 2026Amir Weiss (C-suite exec)Bought (not open market)$49K
Aug 21, 2026Amir Weiss (C-suite exec)Bought (not open market)$47.9K
Aug 21, 2026Ronit Satchi-Fainaro (Insider)Sold$15.5K
Aug 17, 2026Evan Lippman (VP)Sold$680K
Aug 5, 2026Tal Zvi Zaks (Insider)Sold$593
Aug 3, 2026Eric A Hughes (Insider)Sold$892K
Aug 3, 2026Placid Jover (Insider)Sold$447K
Aug 3, 2026Placid Jover (Insider)Bought (not open market)—
Aug 3, 2026Placid Jover (Insider)Bought (not open market)—
Aug 3, 2026Eric A Hughes (Insider)Bought (not open market)—
Aug 3, 2026Eric A Hughes (Insider)Bought (not open market)—
Jun 18, 2026Matthew Shields (VP)Sold$322K
Jun 11, 2026Eliyahu Sharon Kalif (CFO)Sold$3.6M
Jun 5, 2026Richard D Francis (CEO)Sold$211K
Jun 5, 2026Amir Elstein (Insider)Bought (not open market)—
Jun 5, 2026Richard D Francis (CEO)Bought (not open market)—
Jun 5, 2026Gerald M Lieberman (Insider)Bought (not open market)—

Who's trading TEVA

Get free alerts when an insider at Teva Pharmaceutical Industries Ltd files a new trade →